Trial
NCT05427981
Anti-suicidal Effects of Buprenorphine In Depressed Individuals
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
New York State Psychiatric Institute
Collaborators
—
Condition
Suicidal Ideation
Intervention
Belbuca Buccal Product
Why stopped
U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will not resume recruitment after the resumption of research.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-14